|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2007;83:S736-S739
© 2007 The Society of Thoracic Surgeons
Department of Cardiothoracic Surgery, Falk Cardiovascular Research Center, Stanford University Medical School, Stanford, California
* Address correspondence to Dr Miller, Department of Cardiothoracic Surgery, Falk Cardiovascular Research Center, ULN, Stanford University Medical School, 300 Pasteur Dr, Stanford, CA 94305. (Email: dcm{at}stanford.edu).
Presented at Aortic Surgery Symposium X, New York, NY, April 2728, 2006.
Since Sir Magdi Yacoub pioneered aortic root "remodeling" in 1979 [1, 2] and Tirone David [3] followed in 1988 with the "reimplantation" method to preserve the patients native aortic valve when replacing an aortic root aneurysm with a graft, both procedures have been demonstrated to be applicable to many patients with aortic root pathology and aortic regurgitation (AR), including those with the Marfan syndrome (MFS) [4]. The hope has been that cumulative valve-related morbidity and mortality would be lower after a valve-sparing operation compared with after composite valve grafting utilizing a mechanical prosthesis and indefinite warfarin anticoagulation, which represents the surgical "gold standard." While preserving the native aortic valve liberates the patient from the need for life-long anticoagulation, the unanswered question has been valve durability after a Yacoub or David procedure. The popularity of valve-sparing aortic root replacement has escalated rapidly recently owing in no small part to patient demand, but the key question remains [4]: How many years without warfarin will the valve last before a second operation might become necessary? This also is the rationale for the ongoing international registry in 22 North American and European centers sponsored by the National Marfans Foundation comparing composite valve grafting with various types of valve-sparing aortic root replacement procedures in MFS patients. In the interim, what do we know with any modicum of certainty? Based on currently available knowledge, valve durability unfortunately has not been universally satisfactory, prompting some well-known centers to argue that valve-sparing aortic root replacement should be abandoned or limited just to those patients who cannot safely receive anticoagulation therapy [5, 6]. Further, the mortality rate for valve-sparing aortic root replacement has been excessive in other centers [7]. These problems are related in part to surgeon inexperience in aortic root surgery, surgeon unfamiliarity with the pathological anatomy, lack of conceptual understanding of the procedure by surgeons (eg, unnecessarily using pledgeted sutures inside the left ventricular outflow tract tied firmly to the graft), and false surgical pride.
First, the 15- to 20-year results after composite valve grafting in patients with MFS were shown by Gott and colleagues [8] to be outstanding if operation was performed electively before acute aortic dissection or aortic rupture. Morbidity attributed to anticoagulant-related complications was rare, and the thromboembolic and prosthetic valve endocarditis rates were low. Thus, the clinical performance bar has been set very high: the incidence of valve-related morbidity and mortality after valve-sparing aortic root replacement must equal or exceed these standards [4]. Either type of valve-sparing aortic root replacement is safe, fairly reproducible, and associated with reasonable results in selected patients, at least in the hands of certain surgeons. The surgical learning curve, however, is very steep and unforgiving. If the aortic valve cusps are not pathologically damaged, the vast majority of these valves can be conserved; relative contraindications in the past (eg, very large aortic annulus, severe AR or eccentric AR jet due to cusp prolapse, or both, and so forth) have been overcome with new surgical techniques.
The outcomes at 10 years and beyond notwithstanding excellent survival statistics, however, are not ideal. Even in the best surgical centers, 25% to 30% of MFS patients undergoing valve-sparing aortic root replacement have 3+/4+ recurrent AR at 10 years, and small numbers have required aortic valve replacement (AVR) [9]. The long-term durability data are still scanty and follow-up is limited, but most surgical authorities today use the David reimplantation method (including creation of Dacron pseudosinuses) since one can adjust annulus size to whatever is ideal for that individual patient and the annulus cannot dilate postoperatively [4]. The incidence of postoperative bleeding is higher after a Yacoub procedure [9]. Professor Sir Magdi Yacoubs personal results in 82 MFS patients showed that 17% required reoperation by 10 years, and an additional 22% had moderate AR at the time of last follow-up (mean, 5.5 years; median, 3) [10]. Discouraging results at Johns Hopkins in children and young adults after Yacoub procedures prompted Cameron to switch to the David technique in 2002 [11]. The Hannover (Germany) 1993 to 2005 experience (exclusively T. David-I reimplantation using a cylindrical graft) totals 325 patients, 59 of whom had MFS [12]. Freedom from AVR was 80% ± 9% at 10 years, but MFS was a risk factor for late AVR. Davids most recent updated experience in 220 patients (40% with MFS; mean age, 46 years; average follow-up, 5.2 ± 4 years) revealed an operative mortality of 1% (3 of 220) and overall freedom estimate from 3+ or 4+ AR of 85% ± 5% at 10 years (94% ± 4% after David reimplantation versus 75% ± 10% after Yacoub remodeling, p = 0.04) [13]. Late AVR was necessary in 5 patients (freedom from AVR at 10 years was 95% ± 3%). David and colleagues [13] concluded that the reimplantation method proffers better durability; however, it should be noted that multivariable analysis using propensity score matching or case control statistical techniques were not employed to test this hypothesis rigorously, as the Yacoub and David patient cohorts differed.
The basis for my opinion and prejudices rests on our 13-year experience at Stanford, where we have performed 134 valve-sparing aortic root replacement procedures between July 1993 and April 2006. Seventy-two patients had MFS. There were a total of 120 T. David reimplantations and 14 Yacoub remodeling procedures (Fig 1). We started with the T. David-I operation and then tried the Yacoub technique in the late 1990s; even though the remodeling approach is quicker and saves one suture line, one reoperation due to annular dilatation and recurrent AR prompted abandoning the Yacoub approach after 12 adult cases. We then reverted to the T. David-IV technique, and in May 2001 (the same month Dr David independently but similarly began using a larger graft necked down both proximally at the annulus and distally at the sinotubular junction) adopted the T. David-V method.
|
On the other hand, one can oversize the proximal graft excessively; I do not concur with Aybek and colleagues [15] or Gleason [16] who use a "2 · h + 2" (h = average cusp height in mm) formula to select the proper proximal graft size, nor does David [17]. In many patients, reducing the size of a dilated aortic annulus is an essential element of the operation to restore valvular competency; this is easily accomplished by necking down the proximal end of the large graft with several small plicating sutures [14], taking care to calculate that this will be the external diameter of the aortic annulus, not the internal diameter. Being able to cut off the large graft above the top of the commissures facilitates visualizing the sinus rim reimplantation suture line (instead of sewing inside a long, small caliber "chimney" graft as in the T. David-I technique) and allows recreation of more optimal three-dimensional geometry of the sinuses and cusp hinge lines, especially in patients with MFS who have very tall commissures (upward of 5 cm in length) and a relatively bulky rim of aortic tissue contiguous with the hinge of the cusps [14]. In recent years, I have shortened the free margin of one or more aortic cusps in more than 75% of cases; this is done using a 6-0 Gore-Tex (W.L. Gore & Assoc, Flagstaff, Arizona) suture to imbricate the central portion of the cusp (the nodulus of Aranti) to correct preexistent cusp prolapse (associated with eccentric AR) or to craft an equal and high coaptation level for all three cusps (striving to create greater than 5 mm of cusp coaptation zone) or when making a large annulus much smaller inadvertently creates prolapse, usually involving the right or noncoronary cusp.
There has been only 1 operative death (secondary to complications arising from a nondominant right coronary artery anastomosis in a teenager who also required concomitant total arch replacement) among the first-time cases, and 1 late death (suicide). Two patients have required reoperation owing to recurrent AR: a woman, 7 years after a T. David-I (cusp edges thickened and retracted), and a very young man with MFS who had marked annular dilatation 2 years after a Yacoub remodeling procedure. Progressive mitral regurgitation prompted reoperation in a third patient. At 10 years, we are very satisfied with the durability of the David reimplantation method; all patients have zero or 1+, nonprogressive AR on serial follow-up echocardiograms. Conversely, some of the adult Yacoub patients do have 2+ AR, but it is not yet progressing. Postoperatively, we assessed aortic root and downstream aortic flow velocities and flow patterns using phase contrast, time-resolved magnetic resonance imaging in patients after various types of valve-sparing aortic root replacement procedures and in normal volunteers [18]. This work determined that the flow conditions after a T. David-V or T. David-V Stanford modification procedure more closely mimicked that seen normally, and eliminated the tightly helically wound, very fast velocity flow in the distal ascending aorta seen after the T. David-I operations. This more physiologic flow may or may not translate into better valve durability over the long term, but should reduce the abnormal shear stresses imposed on the arch and proximal descending thoracic aorta downstream.
In summary, the surgeon must always put the patients welfare first and foremost. The key question is not if the valve can be spared, but will the preserved aortic valve function well for 10 years or longer? Seasoned surgical judgment and judicious patient selection are essential in deciding whether valve-sparing root replacement is the best option for any given patient. It is also implicit, but needs to be reemphasized to the patients, that a patient who chooses valve-sparing root replacement must understand and accept that a second operation may be necessary in the future. The future results of the National Marfans Foundation prospective aortic root replacement registry will tell us which specific technique is best for patients with MFS. Patients should seek out a cardiac surgeon who has considerable personal experience with valve-sparing aortic root replacement, as this procedure remains more art than science and is most unforgiving of small technical errors in dynamic three-dimensional geometry.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
| General Reading List |
|---|
|
|
|---|
1. Yacoub MH, Gehle P, Chandrasekaran V, Birks EJ, Child A, Radley-Smith R. Late results of a valve-preserving operation in patients with aneurysms of the ascending aorta and root J Thorac Cardiovasc Surg 1998;115:1080-1090.
2. Kvitting J-PE, Ebbers T, Wigström L, Engvall J, Olin CL, Bolger AF. Flow patterns in the aortic root and the aorta studied with time-resolved, 3-dimensional, phase-contrast magnetic resonance imaging: implications for aortic valvesparing surgery J Thorac Cardiovasc Surg 2004;127:1602-1607.
3. Thubrikar MJ, Labrosse MR, Zehr KJ, Robicsek F, Gong GG, Fowler BL. Aortic root dilatation may alter the dimensions of the valve leaflets Eur J Cardiothorac Surg 2005;28:850-856.
4. Demers P, Liang D, Miller DC. Simultaneous "Tirone DavidV" valve-sparing aortic root replacement and radical mitral valve repair for the Marfan syndrome with Barlow syndrome Circulation 2003;108:e116-e117.
5. Yun KL, Miller DC, Fann JI, et al. Composite valve graft versus separate aortic valve and ascending aortic replacementIs there still a role for the separate procedure?. Circulation 1997;96(Suppl 2):368-375.
7. Leyh RG, Schmidtke C, Sievers H-H, Yacoub MH. Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery Circulation 1999;100:2153-2160.
8. Tambeur L, David TE, Unger M, Armstrong S, Ivanov J, Webb G. Results of surgery for aortic root aneurysm in patients with the Marfan syndrome Eur J Cardiothorac Surg 2000;17:415-419.
9. David TE, Armstrong S, Ivanov J, Feindel CM, Omran A, Webb G. Results of aortic valvesparing operations J Thorac Cardiovasc Surg 2001;122:39-46.
10. David TE, Armstrong S, Ivanov J, Webb GD. Aortic valve sparing operations: an update Ann Thorac Surg 1999;67:1840-1842.
11. David TE, Feindel CM, Bos J. Repair of the aortic valve in patients with aortic insufficiency and aortic root aneurysm J Thorac Cardiovasc Surg 1995;109:345-352.
12. Schäfers H-J, Fries R, Langer F, Nikoloudakis N, Graeter T, Grundmann U. Valve-preserving replacement of the ascending aorta: remodeling versus reimplantation J Thorac Cardiovasc Surg 1998;116:990-996.
13. Luciani GB, Casali G, Tomezzoli A, Mazzucco A. Recurrence of aortic insufficiency after aortic root remodeling with valve preservation Ann Thorac Surg 1999;67:1849-1852.
14. El Khoury GA, Underwood MJ, Glineur D, Derouck D, Dion RA. Reconstruction of the ascending aorta and aortic root: experience in 45 consecutive patients Ann Thorac Surg 2000;70:1246-1250.
15. Svensson LG, Longoria J, Kimmel WA, Nadolny E. Management of aortic valve disease during aortic surgery Ann Thorac Surg 2000;69:778-784.
16. Hvass U. A new technique for sparing the aortic valve in patients with aneurysm of the ascending aorta and root J Thorac Cardiovasc Surg 2000;119:1048-1049.
17. Schäfers H-J, Langer F, Aicher D, Graeter TP, Wendler O. Remodeling of the aortic root and reconstruction of the bicuspid aortic valve Ann Thorac Surg 2000;70:542-546.
18. Graeter TP, Langer F, Nikoloudakis N, Aicher D, Schäfers H-J. Valve-preserving operation in acute aortic dissection type A Ann Thorac Surg 2000;70:1460-1465.
19. Langer F, Graeter T, Nikoloudakis N, Aicher D, Wendler O, Schäfers H-J. Valve-preserving aortic replacement: does the additional repair of leaflet prolapse adversely affect the results? J Thorac Cardiovasc Surg 2001;122:270-277.
20. Cochran RP, Kunzelman KS, Eddy AC, Hofer BO, Verrier ED. Modified conduit preparation creates a pseudosinus in an aortic valvesparing procedure for aneurysm of the ascending aorta J Thorac Cardiovasc Surg 1995;109:1049-1058.
21. Grande-Allen KJ, Cochran RP, Reinhall PG, Kunzelman KS. Re-creation of sinuses is important for sparing the aortic valve: a finite element study J Thorac Cardiovasc Surg 2000;119:753-763.
22. van Son JAM, Battellini R, Mierzwa M, Walther T, Autschbach R, Mohr FW. Aortic root reconstruction with preservation of native aortic valve and sinuses in aortic root dilatation with aortic regurgitation J Thorac Cardiovasc Surg 1999;117:1151-1156.
23. Simon P, Moritz A, Moidl R, et al. Aortic valve resuspension in ascending aortic aneurysm repair with aortic insufficiency Ann Thorac Surg 1995;60:176-180.
24. Kallenbach K, Pethig K, Leyh RG, Baric D, Haverich A, Harringer W. Acute dissection of the ascending aorta: first results of emergency valve sparing aortic root reconstruction Eur J Cardiothorac Surg 2002;22:218-222.
25. Pethig K, Milz A, Hagl C, Harringer W, Haverich A. Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early failure Ann Thorac Surg 2002;73:29-33.
26. Kallenbach K, Pethig K, Schwarz M, Milz A, Haverich A, Harringer W. Valve sparing aortic root reconstruction versus composite replacementperioperative course and early complications Eur J Cardiothorac Surg 2001;20:77-81.
27. Harringer W, Pethig K, Hagl C, Meyer GP, Haverich A. Ascending aortic replacement with aortic valve reimplantation Circulation 1999;100(Suppl 2):24-28.
28. Leyh RG, Fischer S, Ruhparwar A, Karck M, Harringer W, Haverich A. Valve-sparing aortic root replacement in patients after a previous operation for acute type A aortic dissection J Thorac Cardiovasc Surg 2002;123:377-378.
29. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Buratta M, Chiariello L. Opening and closing characteristics of the aortic valve after valve-sparing procedures using a new aortic root conduit Ann Thorac Surg 2001;72:487-494.
30. De Paulis R, De Matteis GM, Nardi P, Scaffa R, Bassano C, Chiariello L. Analysis of valve motion after reimplantation type of valve-sparing procedure (David-I) with a new aortic root conduit Ann Thorac Surg 2002;74:53-57.
31. De Paulis R, De Matteis GM, Nardi P, et al. One-year appraisal of a new aortic root conduit with sinuses of Valsalva J Thorac Cardiovasc Surg 2002;123:33-39.
32. Bassano C, De Matteis GM, Nardi P, et al. Mid-term follow-up of aortic root remodelling compared with the Bentall operation Eur J Cardiothorac Surg 2001;19:601-605.
33. Thubrikar MJ, Robicsek F, Gong GG, Fowler BL. A new aortic root prosthesis with compliant sinuses for valve-sparing operations Ann Thorac Surg 2001;71(Suppl):318-322.
34. Robicsek F, Thubrikar MJ, Fokin AA. Cause of degenerative disease of the trileaflet aortic valve: review of subject and presentation of a new theory Ann Thorac Surg 2002;73:1346-1354.
35. Zehr KJ, Thubrikar MJ, Gong GG, Headrick JR, Robicsek F. Clinical introduction of a novel prosthesis for valve-preserving aortic root reconstruction for annuloaortic ectasia J Thorac Cardiovasc Surg 2000;120:692-698.
36. Leyh RG, Schmidtke C, Bartels C, Sievers H-H. Valve-sparing aortic root replacement (remodeling/reimplantation) in acute type A dissection Ann Thorac Surg 2000;70;:21-24.
37. Sundt TM, Moon MR, Xu H. Reoperation for dilatation of the pulmonary artery autograft after the Ross procedure J Thorac Cardiovasc Surg 2001;122:1249-1252.
38. Schmidtke C, Stierle U, Sievers H-H. Valve-sparing aortic root remodeling for pulmonary autograft aneurysm J Heart Valve Dis 2002;11:504-505.[Medline]
39. Massih TA, Vouhé PR, Mauriat P, Mousseaus E, Sidi D, Bonnet D. Replacement of the ascending aorta in children: a series of fourteen patients J Thorac Cardiovasc Surg 2002;124:411-413.
40. Vricella LA, Williams JA, Ravekes WJ, et al. Early experience with valve-sparing aortic root replacement in children Ann Thorac Surg 2005;80:1622-1627.
41. Bethea BT, Fitton TP, Alejo DE, et al. Results of aortic valve-sparing operations: experience with remodeling and reimplantation procedures in 65 patients Ann Thorac Surg 2004;78:767-772.
42. Erasmi A, Sievers H-H, Scharfschwerdt M, Eckel T, Misfeld M. In vitro hydrodynamics, cusp-bending deformation, and root distensibility for different types of aortic valvesparing operations: remodeling, sinus prosthesis, and reimplantation J Thorac Cardiovasc Surg 2005;130:1044-1049.
This article has been cited by other articles:
![]() |
J. I. Fann Invited commentary Ann. Thorac. Surg., September 1, 2007; 84(3): 1006 - 1006. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |